Serial angiographic follow-up beyond 10 years after coronary artery bypass grafting.

BACKGROUND The long-term prognosis and serial angiographic follow-up beyond 10 years in patients who underwent coronary artery bypass grafting (CABG) have not been fully studied in Japan. METHODS AND RESULTS In the present study data from 71 patients who underwent CABG before 1992 were analyzed. Thirty patients had a saphenous vein graft (SVG) only group, and the remaining 41 had a left internal thoracic artery graft to the left anterior descending coronary artery (LITA) group; 6 patients died from malignancy, which was the most common cause of death after CABG. The major adverse cardiac events (MACE) were defined as cardiac death, Q-wave or nonQ-wave myocardial infarction, and congestive heart failure. The MACE-free rate was significantly higher in the LITA group than in the SVG group (p < 0.05). However, among the patients with an ejection fraction < 0.40, there was no significant difference in MACE-free rate between the 2 groups. The LITA patency rate was significantly higher than that for SVG (p < 0.05) and the SVG patency rate was lower in the patients with hyperlipidemia (p < 0.05); cholesterol-lowering therapy improved the SVG patency rate. CONCLUSION The long-term outcome of CABG was favorable, particularly if using an arterial graft. Although the patency rate was lower for the SVG than LITA, the patient's lipid profile might be an important factor in the SVG patency rate.

[1]  Márta Hogye,et al.  [Management of chronic heart failure]. , 2005, Orvosi hetilap.

[2]  C. Izumi,et al.  Usefulness of high-frequency transthoracic Doppler echocardiography in noninvasive diagnosis of the left internal thoracic artery graft stenosis at the anastomosis. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[3]  G. Rubin,et al.  New method of measuring coronary diameter by electron-beam computed tomographic angiography using adjusted thresholds determined by calibration with aortic opacity. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[4]  Y. Tomizawa,et al.  Benefit of Bilateral Over Single Internal Mammary Artery Grafts for Multiple Coronary Artery Bypass Grafting , 2001, Circulation.

[5]  Bruce H. R. Wolffenbuttel,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.

[6]  S. Yusuf,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[7]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[8]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[9]  R. Collins,et al.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[10]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[11]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[12]  A. Voors,et al.  Low recurrence of angina pectoris after coronary artery bypass graft surgery with bilateral internal thoracic and right gastroepiploic arteries. , 1998, Circulation.

[13]  R. Rosenson,et al.  Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. , 1998, JAMA.

[14]  J. M. Bloom.  Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. , 1998, The New England journal of medicine.

[15]  M. Leon,et al.  Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. , 1997, The New England journal of medicine.

[16]  Post Coronary Artery Bypass Graft Trial Investigators.  The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. , 1997, The New England journal of medicine.

[17]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[18]  G. E. Green,et al.  Internal thoracic artery grafts: 20-year clinical follow-up. , 1995, Journal of the American College of Cardiology.

[19]  D. Faxon,et al.  Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. , 1993, Journal of the American College of Cardiology.

[20]  J. Copeland,et al.  Starting Aspirin Therapy After Operation: Effects on Early Graft Patency , 1991, Circulation.

[21]  S. Phillips,et al.  Internal mammary artery versus saphenous vein graft to the left anterior descending coronary artery: prospective randomized study with 10-year follow-up. , 1988, The Annals of thoracic surgery.

[22]  D. Faxon,et al.  Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. , 1988, The New England journal of medicine.

[23]  W Siegenthaler,et al.  Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience. , 1987, The New England journal of medicine.

[24]  F. Loop,et al.  Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. , 1985, The Journal of thoracic and cardiovascular surgery.

[25]  M. Bourassa,et al.  Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. , 1984, The American journal of cardiology.

[26]  A. Gruentzig,et al.  Percutaneous transluminal coronary angioplasty. , 1981, Journal of the Medical Association of Georgia.

[27]  M. Bourassa,et al.  Changes in Grafts and Coronary Arteries After Saphenous Vein Aortocoronary Bypass Surgery: Results at Repeat Angiography , 1982, Circulation.

[28]  G. Duvel.  The study group. , 1980 .

[29]  Sabiston Dc.  The William F. Rienhoff, Jr. lecture. The coronary circulation. , 1974 .

[30]  D. Sabiston.  The William F. Rienhoff, Jr. lecture. The coronary circulation. , 1974, The Johns Hopkins medical journal.

[31]  R. Favaloro,et al.  Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique. , 1969, The Journal of thoracic and cardiovascular surgery.

[32]  S. Stertzer,et al.  Coronary arterial bypass grafts. , 1968, The Annals of thoracic surgery.